Stay updated on Semaglutide for Diabetic Eye Disease Clinical Trial

Sign up to get notified when there's something new on the Semaglutide for Diabetic Eye Disease Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Semaglutide for Diabetic Eye Disease Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    2 days ago
    No Change Detected
  3. Check
    3 days ago
    No Change Detected
  4. Check
    4 days ago
    No Change Detected
  5. Check
    5 days ago
    No Change Detected
  6. Check
    11 days ago
    Change Detected
    Summary
    The value 03 28 has been updated to 05 07 on the webpage, indicating a recent change in the information related to a research study on how Semaglutide compared to placebo affects Diabetic Eye Disease in people with Type 2 Diabetes, sponsored by Novo Nordisk A/S.
    Difference
    0.6%
    Check dated 2024-05-07T20:22:22.000Z thumbnail image
  7. Check
    18 days ago
    Change Detected
    Difference
    3%
    Check dated 2024-04-30T22:45:09.000Z thumbnail image

Stay in the know with updates to Semaglutide for Diabetic Eye Disease Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Semaglutide for Diabetic Eye Disease Clinical Trial page.